G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis

By Huang Hang   Cai Bing  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1177-1182

Springer Publishing Company

Access to resources Recommend Favorite

The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews

By Quintana-Murci Lluís   Gal Inbar   Bakhan Tangiz   Quach Hélène   Sayar S   Shiri-Sverdlov Ronit   Baruch Ruth   McElreavey Ken   Dagan Efrat   Narod Steven   Friedman Eitan  

Familial Cancer, Vol. 4, Iss. 2, 2005-06 ,pp. : 85-88

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of HOXB13 as a molecular marker of recurrent prostate cancer

By                

Molecular Medicine Reports, Vol. 5, Iss. 4, 2012-01 ,pp. : 901-904

Spandidos Publications

Access to resources Recommend Favorite

HOXB13 regulates the prostate-derived Ets factor: Implications for prostate cancer cell invasion

By Kim In-Je   Kang Taek Won   Jeong Taeoh   Kim Young-Rang   Jung Chaeyong  

International Journal of Oncology, Vol. 45, Iss. 2, 2014-08 ,pp. : 869-876

Spandidos Publications

Access to resources Recommend Favorite

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study

By Leiserowitz Gary  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 35-36

Informa Healthcare

Access to resources Recommend Favorite